Varav Tradex Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.97 M
as on 24-10-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.00 Cr
as on 24-10-2024
- Revenue 3.61%
(FY 2023)
- Profit 4.67%
(FY 2023)
- Ebitda 4.12%
(FY 2023)
- Net Worth 0.21%
(FY 2023)
- Total Assets 0.18%
(FY 2023)
About Varav Tradex
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.97 M.
The company currently has active open charges totaling ₹14.00 Cr.
Manoj Garg, Ashok Kumar, and Charanjit Kumar serve as directors at the Company.
- CIN/LLPIN
U51909HR2010PTC040527
- Company No.
040527
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2010
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panipat, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Varav Tradex?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Garg  | Director | 13-May-2010 | Current |
| Ashok Kumar | Director | 13-May-2010 | Current |
| Charanjit Kumar | Director | 13-May-2010 | Current |
Financial Performance of Varav Tradex.
Varav Tradex Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.61% increase. The company also saw a slight improvement in profitability, with a 4.67% increase in profit. The company's net worth moved up by a moderate rise of 0.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Varav Tradex?
In 2023, Varav Tradex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yug Dyers & Processors Private LimitedActive 17 years 2 monthsManoj Garg and Ashok Kumar are mutual person
- Abble Biological Private LimitedActive 8 years 4 months
Manoj Garg, Ashok Kumar and 1 more are mutual person
- Curewell Drugs And Pharmaceuticals Pvt. Ltd.Active 29 years 8 months
Manoj Garg, Ashok Kumar and 1 more are mutual person
- Horizon Bioceuticals Pvt LtdActive 26 years 2 months
Manoj Garg, Ashok Kumar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 19 Feb 2022 | ₹14.00 Cr | Open |
How Many Employees Work at Varav Tradex?
Unlock and access historical data on people associated with Varav Tradex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Varav Tradex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Varav Tradex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
